Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis

被引：57
作者：
Baghaei, Kaveh [1 ,2 ]
Mazhari, Sogol [1 ]
Tokhanbigli, Samaneh [1 ]
Parsamanesh, Gilda [1 ]
Alavifard, Helia [1 ]
Schaafsma, Dedmer [3 ]
Ghavami, Saeid [4 ,5 ,6 ,7 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Basic & Mol Epidemiol Gastrointestinal Disorders, Tehran 1985717413, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Gastroenterol & Liver Dis Res Ctr, Tehran 1985717413, Iran
[3] Sci Impact, Winnipeg, MB, Canada
[4] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada
[5] Univ Manitoba, Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB R3E 0V9, Canada
[6] Univ Manitoba, Children Hosp Res Inst Manitoba, Biol Breathing Theme, Winnipeg, MB R3E 0V9, Canada
[7] Katowice Sch Technol, Fac Med, PL-40555 Katowice, Poland
来源：
DRUG DISCOVERY TODAY | 2022年 / 27卷 / 04期
关键词：
Liver diseases; Extracellular signaling; Cell phenotype; Fibrogenic myofibroblasts; Autophagy; NF-KAPPA-B; HEDGEHOG SIGNALING INHIBITOR; TGF-BETA; ANTIFIBROTIC ACTIVITY; EXTRACELLULAR-MATRIX; RECEPTOR; AUTOPHAGY; PATHWAY; ANGIOGENESIS; PDGF;
D O I：
10.1016/j.drudis.2021.12.012
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Hepatic fibrosis is a manifestation of different etiologies of liver disease with the involvement of multiple mediators in complex network interactions. Activated hepatic stellate cells (aHSCs) are the central driver of hepatic fibrosis, given their potential to induce connective tissue formation and extracellular matrix (ECM) protein accumulation. Therefore, identifying the cellular and molecular pathways involved in the activation of HSCs is crucial in gaining mechanistic and therapeutic perspectives to more effectively target the disease. In addition to a comprehensive summary of our current understanding of the role of HSCs in liver fibrosis, we also discuss here the proposed therapeutic strategies based on targeting HSCs.
引用
收藏
页码：1044 / 1061
页数：18
相关论文
共 166 条
[61]   Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues [J].
Hernandez-Gea, Virginia ;
Ghiassi-Nejad, Zahra ;
Rozenfeld, Raphael ;
Gordon, Ronald ;
Fiel, Maria Isabel ;
Yue, Zhenyu ;
Czaja, Mark J. ;
Friedman, Scott L. .
GASTROENTEROLOGY, 2012, 142 (04) :938-946
[62]   CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation [J].
Hintermann, Edith ;
Bayer, Monika ;
Pfeilschifter, Josef M. ;
Luster, Andrew D. ;
Christen, Urs .
JOURNAL OF AUTOIMMUNITY, 2010, 35 (04) :424-435
[63]   Antifibrotic Activity of Sorafenib in Experimental Hepatic Fibrosis: Refinement of Inhibitory Targets, Dosing, and Window of Efficacy In Vivo [J].
Hong, Feng ;
Chou, Hsini ;
Fiel, Maria Isabel ;
Friedman, Scott L. .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (01) :257-264
[64]   Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis [J].
Hu, Chenxia ;
Zhao, Lingfei ;
Duan, Jinfeng ;
Li, Lanjuan .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (03) :1657-1670
[65]   New insights into TGF-β/Smad signaling in tissue fibrosis [J].
Hu, He-He ;
Chen, Dan-Qian ;
Wang, Yan-Ni ;
Feng, Ya-Long ;
Cao, Gang ;
Vaziri, Nosratola D. ;
Zhao, Ying-Yong .
CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 292 :76-83
[66]   Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells [J].
Huang, Yangqing ;
Feng, Helin ;
Kan, Tong ;
Huang, Bin ;
Zhang, Minfeng ;
Li, Yesheng ;
Shi, Changying ;
Wu, Mengchao ;
Luo, Yunquan ;
Yang, Jiamei ;
Xu, Feng .
PLOS ONE, 2013, 8 (08)
[67]   Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis [J].
Huang, Yue-Hong ;
Chen, Ming-Hua ;
Guo, Qi-Lan ;
Chen, Zhi-Xin ;
Chen, Qing-Duo ;
Wang, Xiao-Zhong .
CELLULAR SIGNALLING, 2020, 66
[68]   Origin of myofibroblasts in the fibrotic liver in mice [J].
Iwaisako, Keiko ;
Jiang, Chunyan ;
Zhang, Mingjun ;
Cong, Min ;
Moore-Morris, Thomas Joseph ;
Park, Tae Jun ;
Liu, Xiao ;
Xu, Jun ;
Wang, Ping ;
Paik, Yong-Han ;
Meng, Fanli ;
Asagiri, Masataka ;
Murray, Lynne A. ;
Hofmann, Alan F. ;
Iida, Takashi ;
Glass, Christopher K. ;
Brenner, David A. ;
Kisseleva, Tatiana .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (32) :E3297-E3305
[69]   Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1 [J].
Jo, Seunghyun ;
Kim, Eunsom ;
Kwak, Areum ;
Lee, Jungmin ;
Hong, Jaewoo ;
Lee, Jongho ;
Youn, Sulah ;
Bae, Suyoung ;
Kim, Busun ;
Ryoo, Soyoon ;
Kang, Tae-Bong ;
Her, Erk ;
Choi, Dong-Ki ;
Kim, Yong-Sung ;
Lee, Youngmin ;
Jhun, Hyunjhung ;
Kim, Soohyun .
CYTOKINE, 2016, 83 :33-40
[70]   Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats [J].
Karimi, Jamshid ;
Mohammadalipour, Adel ;
Sheikh, Nasrin ;
Khodadadi, Iraj ;
Hashemnia, Mohammad ;
Goudarzi, Farjam ;
Khanjarsim, Vahid ;
Solgi, Ghasem ;
Hajilooi, Mehrdad ;
Bahabadi, Majid ;
Kheiripour, Nejat ;
Hedayatyanfard, Keshvad .
DRUG AND CHEMICAL TOXICOLOGY, 2020, 43 (05) :468-478
234567891011